title: Osteoporosis in HIV-infected subjects: a combined effect of highly active antiretroviral therapy and HIV itself?
authors.forename: Marco
authors.initials: M
authors.lastname: Bongiovanni
authors.forename: Alfonso
authors.initials: A
authors.lastname: Fausto
authors.forename: Paola
authors.initials: P
authors.lastname: Cicconi
authors.forename: Laura
authors.initials: L
authors.lastname: Menicagli
authors.forename: Sara
authors.initials: S
authors.lastname: Melzi
authors.forename: Valentina Emanuela
authors.initials: VE
authors.lastname: Ligabo
authors.forename: Giampaolo
authors.initials: G
authors.lastname: Cornalba
authors.forename: Teresa
authors.initials: T
authors.lastname: Bini
authors.forename: Francesco
authors.initials: F
authors.lastname: Sardanelli
authors.forename: Antonella D'Arminio
authors.initials: AD
authors.lastname: Monforte
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced / Q000209:etiology*
chemical_list: D019380:Anti-HIV Agents